JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$2.29B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.1B |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$1.67B |
| 4 |
AbbVie
ABBV
|
+$1.6B |
| 5 |
ExxonMobil
XOM
|
+$1.5B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$3.99B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.15B |
| 4 |
Tesla
TSLA
|
+$1.05B |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.04% |
| 2 | Healthcare | 10.96% |
| 3 | Financials | 10.87% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RXDX
3251
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $3.13M | ﹤0.01% |
82,927
+67,975
| +455% | +$2.69M |
|
3252
E.W. Scripps
SSP
$320M
| $3.13M | ﹤0.01% |
150,550
-19,287
| -11% | -$407K |
|
3253
Kodiak Sciences
KOD
$2.59B
| $3.12M | ﹤0.01% |
404,726
+367,367
| +983% | +$14.3M |
|
|
OPTU
3254
CALL
Optimum Communications Inc
OPTU
$251M
| $3.12M | ﹤0.01% |
250,000
| – | – |
|
3255
CALL
Viatris
VTRS
$18.6B
| $3.12M | ﹤0.01% |
286,800
-2,487,400
| -90% | -$32.8M |
|
3256
PUT
Lam Research
LRCX
$416B
| $3.12M | ﹤0.01% |
58,000
+3,000
| +5% | +$175K |
|
3257
Equity Bancshares
EQBK
$1.06B
| $3.11M | ﹤0.01% |
96,257
-11,491
| -11% | -$374K |
|
3258
PUT
Ares Capital
ARCC
$14.3B
| $3.11M | ﹤0.01% |
+148,300
| New | +$3.16M |
|
|
PPL
3259
CALL
PPL Corp
PPL
$27.1B
| $3.1M | ﹤0.01% |
108,500
| – | – |
|
3260
PUT
US Bancorp Series B Preferred Stock
USB.PRH
$742M
| $3.1M | ﹤0.01% |
58,300
+22,900
| +65% | +$501K |
|
|
USDP
3261
DELISTED
USD PARTNERS LP
USDP
| $3.08M | ﹤0.01% |
512,198
+199,696
| +64% | +$1.14M |
|
3262
Photronics
PLAB
$1.96B
| $3.08M | ﹤0.01% |
181,577
-32,509
| -15% | -$585K |
|
|
HTPA
3263
DELISTED
Highland Transcend Partners I Corp.
HTPA
| $3.08M | ﹤0.01% |
313,516
+216,516
| +223% | +$2.15M |
|
3264
Impinj
PI
$5.28B
| $3.07M | ﹤0.01% |
48,385
+25,370
| +110% | +$1.83M |
|
3265
Nkarta
NKTX
$167M
| $3.07M | ﹤0.01% |
270,124
-5,140
| -2% | -$55K |
|
|
TRST
3266
Trustco Bank Corp NY
TRST
$977M
| $3.06M | ﹤0.01% |
96,012
-31,959
| -25% | -$1.08M |
|
3267
FuelCell Energy
FCEL
$1.79B
| $3.06M | ﹤0.01% |
17,711
+655
| +4% | +$104K |
|
3268
Akebia Therapeutics
AKBA
$242M
| $3.06M | ﹤0.01% |
4,258,198
-174,005
| -4% | -$372K |
|
3269
Helios Technologies
HLIO
$2.69B
| $3.06M | ﹤0.01% |
38,072
-35,146
| -48% | -$2.8M |
|
3270
SandRidge Energy
SD
$520M
| $3.06M | ﹤0.01% |
190,697
+24,007
| +14% | +$310K |
|
3271
State Street SPDR S&P Insurance ETF
KIE
$684M
| $3.05M | ﹤0.01% |
72,644
-127
| -0.2% | -$5.12K |
|
|
ALLK
3272
DELISTED
Allakos
ALLK
| $3.05M | ﹤0.01% |
535,368
+409,478
| +325% | +$2.65M |
|
3273
Fidelity MSCI Health Care Index ETF
FHLC
$3.4B
| $3.05M | ﹤0.01% |
46,435
+231
| +0.5% | +$14.7K |
|
|
GMDA
3274
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $3.04M | ﹤0.01% |
731,328
+83,009
| +13% | +$278K |
|
|
CHAA
3275
DELISTED
Catcha Investment Corp
CHAA
| $3.03M | ﹤0.01% |
309,791
-8,109
| -3% | -$79K |
|
Similar funds
JP Morgan Chase's Q1 2022 Portfolio in Review
As of Q1 2022, JP Morgan Chase held 7,378 positions worth $830B, down 4.1% from $866B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2022 filing shows 607 new, 2,657 increased, 2,665 reduced and 679 closed positions. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M. The largest sale was Vanguard Short-Term Bond ETF, an estimated $3.99B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2022 buy was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M.
- JP Morgan Chase added most to Vanguard Total Bond Market in Q1 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q1 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.99B.
- JP Morgan Chase fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $442M.
- JP Morgan Chase's ten largest holdings make up 18% of its $830B portfolio in Q1 2022.
- JP Morgan Chase opened 607 new positions and closed 679 in Q1 2022.
- JP Morgan Chase's portfolio value fell 4.1% quarter-over-quarter to $830B.
Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.